U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07057089) titled 'Involved-field Radiotherapy-TNT Combined With PD-1 Inhibitor for pMMR Locally Advanced Rectal Cancer (Neo-Field I)' on June 29.
Brief Summary: The purpose of this study is to explore the efficacy and safety of involved-field radiotherapy-TNT combined with PD-1 inhibitors in pMMR locally advanced rectal cancer.
Study Start Date: July 01
Study Type: INTERVENTIONAL
Condition:
Locally Advanced Rectal Cancer
Intervention:
DRUG: Capecitabine
Capecitabine: 825mg/m2, bid;
DRUG: Camrelizumab
Camrelizumab: 200mg
DRUG: CAPOX
CAPOX
RADIATION: Involve-field irradiation
Involve-field irradiation: Primary rectal tumor + metastatic or ...